USFDA auditors have inspected Shilpa Medicare Ltd’s manufacturing facilities located at Deosugur Industrial Area, Deosugur, Raichur (Karnataka).
The auditors have also inspected its 100 per cent EOU facility at Raichur Industrial Growth Centre, Wadloor Road, Chicksugur Cross, Chicksugur, Raichur (Karnataka).
The company in a release to exchanges said that the results of the audit are awaited.
Business Line
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…